Jane Street Group, LLC Insmed Inc Put Options Transaction History

Jane Street Group, LLC

10 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$62.0 - $79.01 $64.7 Million - $82.4 Million	1,042,800 New	1,042,800 $76.1 Million
Q4 2021 Feb 15, 2022	BUY	$25.89 - $33.45 $574,758 - $742,590	22,200 Added 215.53%	32,500 $885,000
Q3 2021 Nov 16, 2021	BUY	$22.46 - $29.47 $2,246 - $2,947	100 Added 0.98%	10,300 $284,000
Q2 2021 Aug 16, 2021	SELL	$24.17 - $36.01 $352,882 - $525,746	-14,600 Reduced 58.87%	10,200 $290,000
Q1 2021 May 18, 2021	SELL	$32.28 - $44.3 $284,064 - $389,840	-8,800 Reduced 26.19%	24,800 $845,000
Q4 2020 Feb 17, 2021	BUY	$31.45 - $40.54 $75,480 - $97,296	2,400 Added 7.69%	33,600 $1.12 Million
Q3 2020 Nov 17, 2020	SELL	$26.0 - $34.5 $790,400 - $1.05 Million	-30,400 Reduced 49.35%	31,200 $1 Million
Q2 2020 Aug 17, 2020	BUY	$14.11 - $29.42 $558,756 - $1.17 Million	39,600 Added 180.0%	61,600 $1.7 Million
Q1 2020 May 15, 2020	SELL	$13.63 - $33.98 $13,630 - $33,980	-1,000 Reduced 4.35%	22,000 $353,000
Q3 2017 Nov 14, 2017	BUY	$11.61 - $31.21 $267,030 - $717,830	23,000	23,000 $718,000

467

182M

2.27M

3.33M

Ticker INSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 135,476,992
Market Cap $9.81B
Description
Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.